Cancer and Genetic Counseling

  • Brandie Heald
  • James M. Church


All cancer is genetic. Cancer is a disease caused by an accumulation of genetic damage that interferes with the regulation of cell growth, differentiation, and death. Most cancer-causing genetic damage is acquired either due to environmental exposures, carcinogens, or chance.


Genetic Testing Genetic Counselor Deleterious Mutation Multiple Endocrine Neoplasia Genetic Discrimination 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet Med 11, 35–41 (2009).Google Scholar
  2. 2.
    Khatcheressian, J.L. et al. American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol 24, 5091–7 (2006).PubMedCrossRefGoogle Scholar
  3. 3.
    Lancaster, J.M. et al. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions. Gynecol Oncol 107, 159–62 (2007).PubMedCrossRefGoogle Scholar
  4. 4.
    Murphy, C.D. et al. The American Cancer Society guidelines for breast screening with magnetic resonance imaging: an argument for genetic testing. Cancer 113, 3116–20 (2008).PubMedCrossRefGoogle Scholar
  5. 5.
    Winawer, S. et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology 124, 544–60 (2003).PubMedCrossRefGoogle Scholar
  6. 6.
    Trepanier, A. et al. Genetic cancer risk assessment and counseling: recommendations of the national society of genetic counselors. J Genet Couns 13, 83–114 (2004).PubMedCrossRefGoogle Scholar
  7. 7.
    Dudley-Brown, S. & Freivogel, M. Hereditary colorectal cancer in the gastroenterology clinic: how common are at-risk patients and how do we find them? Gastroenterol Nurs 32, 8–16 (2009).PubMedCrossRefGoogle Scholar
  8. 8.
    Mitchell, R.J. et al. Accuracy of reporting of family history of colorectal cancer. Gut 53, 291–5 (2004).PubMedCrossRefGoogle Scholar
  9. 9.
    Church, J. & McGannon, E. Family history of colorectal cancer: how often and how accurately is it recorded? Dis Colon Rectum 43, 1540–4 (2000).PubMedCrossRefGoogle Scholar
  10. 10.
    Lynch, H.T. et al. Who should be sent for genetic testing in hereditary colorectal cancer syndromes? J Clin Oncol 25, 3534–42 (2007).PubMedCrossRefGoogle Scholar
  11. 11.
    Murff, H.J., Spigel, D.R. & Syngal, S. Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history. JAMA 292, 1480–9 (2004).PubMedCrossRefGoogle Scholar
  12. 12.
    Tyler, C.V., Jr. & Snyder, C.W. Cancer risk assessment: examining the family physician’s role. J Am Board Fam Med 19, 468–77 (2006).PubMedCrossRefGoogle Scholar
  13. 13.
    Mitchell, R.J. et al. Prevalence of family history of colorectal cancer in the general population. Br J Surg 92, 1161–4 (2005).PubMedCrossRefGoogle Scholar
  14. 14.
    Schneider, K.A. Counseling About Cancer: Strategies for Genetic Counseling, 333 (Wiley-Liss, Inc., New York, 2002).Google Scholar
  15. 15.
    Young, S.R. et al. The prevalence of BRCA mutations among young women with triple-negative breast cancer. BMC Cancer 9, 86 (2009).PubMedCrossRefGoogle Scholar
  16. 16.
    Berry, D.A., Parmigiani, G., Sanchez, J., Schildkraut, J. & Winer, E. Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. J Natl Cancer Inst 89, 227–38 (1997).PubMedCrossRefGoogle Scholar
  17. 17.
    Couch, F.J. et al. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 336, 1409–15 (1997).PubMedCrossRefGoogle Scholar
  18. 18.
    Frank, T.S. et al. Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 20, 1480–90 (2002).PubMedCrossRefGoogle Scholar
  19. 19.
    Shattuck-Eidens, D. et al. BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing. JAMA 278, 1242–50 (1997).PubMedCrossRefGoogle Scholar
  20. 20.
    Stoppa-Lyonnet, D. et al. BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic. Institut Curie Breast Cancer Group. Am J Hum Genet 60, 1021–30 (1997).PubMedGoogle Scholar
  21. 21.
    Tyrer, J., Duffy, S.W. & Cuzick, J. A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 23, 1111–30 (2004).PubMedCrossRefGoogle Scholar
  22. 22.
    Balmana, J. et al. Prediction of MLH1 and MSH2 mutations in Lynch syndrome. JAMA 296, 1469–78 (2006).PubMedCrossRefGoogle Scholar
  23. 23.
    Barnetson, R.A. et al. Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. N Engl J Med 354, 2751–63 (2006).PubMedCrossRefGoogle Scholar
  24. 24.
    Chen, S. et al. Prediction of germline mutations and cancer risk in the Lynch syndrome. JAMA 296, 1479–87 (2006).PubMedCrossRefGoogle Scholar
  25. 25.
    Marroni, F. et al. A genetic model for determining MSH2 and MLH1 carrier probabilities based on family history and tumor microsatellite instability. Clin Genet 69, 254–62 (2006).PubMedCrossRefGoogle Scholar
  26. 26.
    Wijnen, J.T. et al. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer. N Engl J Med 339, 511–8 (1998).PubMedCrossRefGoogle Scholar
  27. 27.
    Giardiello, F.M. et al. The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N Engl J Med 336, 823–7 (1997).PubMedCrossRefGoogle Scholar
  28. 28.
    GeneTests. Medical Genetics Information Resource. (University of Seattle, Washington, 1993–2009).Google Scholar
  29. 29.
    Brandi, M.L. et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86, 5658–71 (2001).PubMedCrossRefGoogle Scholar
  30. 30.
    Aretz, S. et al. High proportion of large genomic STK11 deletions in Peutz-Jeghers syndrome. Hum Mutat 26, 513–9 (2005).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Genomic Medicine Institute and the Sanford R. Weiss Center for Hereditary Colorectal NeoplasioCleveland Clinic FoundationClevelandUSA

Personalised recommendations